Vertex to Present at the Cowen Health Care Conference on March 3
2020年2月26日 - 6:01AM
ビジネスワイヤ(英語)
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today
announced that management will present at the Cowen Health Care
Conference on Tuesday, March 3, 2020 at 10:00 a.m. ET.
The audio portion of management's remarks will be available live
through Vertex's website, www.vrtx.com in the "Investors" section
under the "News and Events" page. A replay of the conference
webcast will be archived on the company's website.
About Vertex
Vertex is a global biotechnology company that invests in
scientific innovation to create transformative medicines for people
with serious diseases. The company has multiple approved medicines
that treat the underlying cause of cystic fibrosis (CF) - a rare,
life-threatening genetic disease - and has several ongoing clinical
and research programs in CF. Beyond CF, Vertex has a robust
pipeline of investigational small molecule medicines in other
serious diseases where it has deep insight into causal human
biology, including pain, alpha-1 antitrypsin deficiency, and
APOL1-mediated kidney disease. In addition, Vertex has a rapidly
expanding pipeline of genetic and cell therapies for diseases such
as sickle cell disease, beta thalassemia, Duchenne muscular
dystrophy and type 1 diabetes mellitus.
Founded in 1989 in Cambridge, Mass., Vertex's global
headquarters is now located in Boston's Innovation District and its
international headquarters is in London, UK. Additionally, the
company has research and development sites and commercial offices
in North America, Europe, Australia and Latin America. Vertex is
consistently recognized as one of the industry's top places to
work, including 10 consecutive years on Science magazine's Top
Employers list and top five on the 2019 Best Employers for
Diversity list by Forbes. For company updates and to learn more
about Vertex's history of innovation, visit www.vrtx.com or follow
us on Facebook, Twitter, LinkedIn, YouTube and Instagram.
(VRTX-WEB)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200225005993/en/
Investors: Michael Partridge, 617-341-6108 Zach Barber,
617-341-6470 Leah Gibson, 617-961-1507
Vertex Pharmaceuticals (NASDAQ:VRTX)
過去 株価チャート
から 6 2024 まで 7 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
過去 株価チャート
から 7 2023 まで 7 2024